| This article has been cited by |
| 1 | The clinical challenges of akathisia | |
| James B. Lohr,Carolyn A. Eidt,Areej Abdulrazzaq Alfaraj,Mounir A. Soliman |
| CNS Spectrums.2015;20(S1)1 |
| [DOI] |
|
| 2 | Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment | |
| Shaina Musco,Vivian McAllister,Ian Caudle |
| Therapeutic Advances in Psychopharmacology.2020;10(S1)204512532093757 |
| [DOI] |
|
| 3 | Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment | |
| P. Chue,J. Chue |
| Therapeutic Advances in Psychopharmacology.2016;38(S1)35 |
| [DOI] |
|
| 4 | Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report | |
| Masahiro Takeshima,Hiroyasu Ishikawa,Yuka Kikuchi,Takashi Kanbayashi,Tetsuo Shimizu |
| Clinical Psychopharmacology and Neuroscience.2018;16(3)346 |
| [DOI] |
|
| 5 | The Role of Antypsychotic Therapy in the Development of Akathisia in Patients with Schizophrenia | |
| A. A. Goncharova,E. G. Kornetova |
| Psychiatry.2020;18(2)32 |
| [DOI] |
|
| 6 | Clozapine | |
| A. A. Goncharova,E. G. Kornetova |
| Reactions Weekly.2016;1588(1)84 |
| [DOI] |
|
